X4 Pharmaceuticals (XFOR) Non-cash Items (2017 - 2019)

X4 Pharmaceuticals has reported Non-cash Items for 3 years, with the latest figure at $7.2 million in Q2 2019.

• For the quarter ending Q2 2019, Non-cash Items rose 3774.59% year-over-year to $7.2 million; the trailing twelve-month figure through Jun 2019 stood at $7.2 million (up 3774.59% YoY), and the FY2018 full-year result was $6.5 million, down 28.94% from the prior year.
• Non-cash Items for Q2 2019 stood at $7.2 million, up from $556774.0 in the prior quarter.
• The five-year high for Non-cash Items was $27.4 million in Q1 2018, with the low at $185000.0 in Q2 2018.
• Historically, Non-cash Items has averaged $8.5 million across 3 years, with a median of $6.8 million in 2018.
• The largest YoY upside for Non-cash Items was 3774.59% in 2019 against a maximum downside of 97.97% in 2019.
• X4 Pharmaceuticals' Non-cash Items stood at $9.1 million in 2017, then decreased by 28.94% to $6.5 million in 2018, then rose by 10.51% to $7.2 million in 2019.
• The last three Non-cash Items figures came in at $7.2 million (Q2 2019), $556774.0 (Q1 2019), and $6.5 million (Q4 2018), per Business Quant data.